Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (AML-19)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by European Organisation for Research and Treatment of Cancer - EORTC.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT00091234
First received: September 7, 2004
Last updated: July 23, 2012
Last verified: July 2012